SCHEMBL20696702

SCHEMBL20696702

CC(C)(C)OC(=O)CC(C)(C)c1ccccc1OP(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
USP2 O75604 1/20 0.42
HPGD P15428 1/20 0.42
PDE3A Q14432 1/20 0.42
HSD17B10 Q99714 1/20 0.42
INPPL1 O15357 3/20 0.39
INPP5A Q14642 3/20 0.39
INPP5B P32019 2/20 0.39
SRC P12931 2/20 0.39
AKT1 P31749 1/20 0.34
PTPRC P08575 2/20 0.34
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NAMPT P43490 1/20 0.33
GAA P10253 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18607332 0.87 KDM4E (0.43) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL5007401 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL18121460 0.83 ALDH1A1 (0.44) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL18114061 0.82 ALDH1A1 (0.43) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL19629845 0.81 ALDH1A1 (0.42) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL27859933 0.79 INPPL1 (0.46) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL20696698 0.78 TSHR (0.36) ALDH1A1KDM4EPTPRCMTNR1AMTNR1B
SCHEMBL20696701 0.78 KDM4E (0.45) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL1354464 0.78 INPPL1 (0.44) ALDH1A1KDM4EUSP2HPGDPDE3A
SCHEMBL20696700 0.77 MTNR1A (0.45) ALDH1A1KDM4EUSP2HPGDPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190315731-A1 6-(BUTA-1,3-DIYN-1-YL)BENZO[D]THIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS, LTD. (CH) 2019-10-17 US disclosed
US-10314823-B2 Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds IDORSIA PHARMACEUTICALS LTD (CH) 2019-06-11 US disclosed
US-20190031676-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315731-A1 6-(BUTA-1,3-DIYN-1-YL)BENZO[D]THIAZOLE DERIVATIVES TMBIM6, BTN3A1, BET1 ALDH1A1 40/4885KDM4E 3497/4885USP2 4835/4885
US-10314823-B2 Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds MRPL21, MRM1, MT-CO1 ALDH1A1 103/4885KDM4E 2265/4885USP2 4611/4885
US-20190031676-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES PYCR1, PSPH, RPSA ALDH1A1 2350/4885KDM4E 2920/4885USP2 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.